Literature DB >> 25583774

Paving the road to clinical trial participation: removing road blocks and directing patients toward novel therapies.

Andrea Wang-Gillam, Kristina Williams.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25583774      PMCID： PMC4687905          DOI： 10.6004/jnccn.2015.0013

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  8 in total

1.  Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.

Authors:  Andrea Wang-Gillam; Kristina Williams; Silvia Novello; Feng Gao; Giorgio V Scagliotti; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

Authors:  David M Dilts; Alan B Sandler; Matthew Baker; Steven K Cheng; Stephen L George; Kathleen S Karas; Stephen McGuire; Gourija S Menon; Jason Reusch; Debbie Sawyer; Maren Scoggins; Amy Wu; Kai Zhou; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

3.  Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group.

Authors:  David M Dilts; Alan Sandler; Steven Cheng; Joshua Crites; Lori Ferranti; Amy Wu; Robert Gray; Jean MacDonald; Donna Marinucci; Robert Comis
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

4.  The impact of insurance on access to cancer clinical trials at a comprehensive cancer center.

Authors:  Justin F Klamerus; Suanna S Bruinooge; Xiaobu Ye; Mandi L Klamerus; Dorothy Damron; Dina Lansey; John C Lowery; Luis A Diaz; Jean G Ford; Norma Kanarek; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

Review 5.  Recent progress in pancreatic cancer.

Authors:  Christopher L Wolfgang; Joseph M Herman; Daniel A Laheru; Alison P Klein; Michael A Erdek; Elliot K Fishman; Ralph H Hruban
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

6.  Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.

Authors:  David M Dilts; Alan B Sandler
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

7.  Pancreatic cancer clinical trials and accrual in the United States.

Authors:  William A Hoos; Porsha M James; Lola Rahib; Anitra W Talley; Julie M Fleshman; Lynn M Matrisian
Journal:  J Clin Oncol       Date:  2013-08-19       Impact factor: 44.544

8.  Screening intervention to identify eligible patients and improve accrual to phase II-IV oncology clinical trials.

Authors:  Leo Chen; Janice Grant; Winson Y Cheung; Hagen F Kennecke
Journal:  J Oncol Pract       Date:  2013-03-05       Impact factor: 3.840
  8 in total
  1 in total

1.  Academic Cancer Center Phase I Program Development.

Authors:  Arthur E Frankel; Keith T Flaherty; George J Weiner; Robert Chen; Nilofer S Azad; Michael J Pishvaian; John A Thompson; Matthew H Taylor; Daruka Mahadevan; A Craig Lockhart; Ulka N Vaishampayan; Jordan D Berlin; David C Smith; John Sarantopoulos; Matthew Riese; Mansoor N Saleh; Chul Ahn; Eugene P Frenkel
Journal:  Oncologist       Date:  2017-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.